Stock VMD VIEMED HEALTHCARE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Viemed Healthcare, Inc.

Equities

VMD

CA92663R1055

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-23 EDT 		5-day change 1st Jan Change
6.9 USD -1.85% Intraday chart for Viemed Healthcare, Inc. -2.40% -12.10%
05-07 Transcript : Viemed Healthcare, Inc., Q1 2024 Earnings Call, May 07, 2024
05-06 Earnings Flash (VMD) VIEMED HEALTHCARE Reports Q1 Revenue $50.6M MT

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation
  • The company has a poor ESG score according to Refinitiv, which ranks companies by sector.

Strengths

  • Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach -99% by 2026.
  • The company's profit outlook over the next few years is a strong asset.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

Weaknesses

  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
VIEMED HEALTHCARE, INC. Stock Viemed Healthcare, Inc.
-12.10% 273M
C-
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+16.49% 83.4B
C+
CVS HEALTH CORPORATION Stock CVS Health Corporation
-29.52% 72.11B
B-
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
0.00% 27.04B
C+
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-13.29% 16.96B
B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+1.03% 16.86B
A-
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+1.57% 15.76B
A-
NATERA, INC. Stock Natera, Inc.
+71.63% 13.33B
C-
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
+1.53% 12.76B
B-
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+70.68% 12.74B
C+
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy
  1. Stock Market
  2. Equities
  3. VMD Stock
  4. Ratings Viemed Healthcare, Inc.